These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32294396)
21. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. Wallace EM; Gow SM; Wu FC J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955 [TBL] [Abstract][Full Text] [Related]
22. Outcomes of anastrozole in oligozoospermic hypoandrogenic subfertile men. Shoshany O; Abhyankar N; Mufarreh N; Daniel G; Niederberger C Fertil Steril; 2017 Mar; 107(3):589-594. PubMed ID: 28069178 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens. Guerin JF; Rollet J Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439 [TBL] [Abstract][Full Text] [Related]
24. A man with hypogonadotropic hypogonadism successfully treated with nasal administration of the low-dose gonadotropin-releasing hormone analog buserelin. Iwamoto H; Yoshida A; Suzuki H; Tanaka M; Watanabe N; Nakamura T Fertil Steril; 2009 Sep; 92(3):1169.e1-1169.e3. PubMed ID: 19591988 [TBL] [Abstract][Full Text] [Related]
25. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men. Behre HM; Heinemann L; Morales A; Pexman-Fieth C Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open-label studies. Belkoff L; Brock G; Carrara D; Neijber A; Ando M; Mitchel J Andrologia; 2018 Feb; 50(1):. PubMed ID: 28295450 [TBL] [Abstract][Full Text] [Related]
27. Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL. Madhusoodanan V; Patel P; Lima TFN; Gondokusumo J; Lo E; Thirumavalavan N; Lipshultz LI; Ramasamy R Int Braz J Urol; 2019; 45(5):1008-1012. PubMed ID: 31408289 [TBL] [Abstract][Full Text] [Related]
28. Compounded percutaneous testosterone gel: use and effects in hypogonadal men. Cutter CB J Am Board Fam Pract; 2001; 14(1):22-32. PubMed ID: 11206690 [TBL] [Abstract][Full Text] [Related]
29. Comparison of Hematocrit Change in Testosterone-deficient Men Treated With Intranasal Testosterone Gel vs Intramuscular Testosterone Cypionate: A Randomized Clinical Trial. Rivero MJ; Ory J; Diaz P; Thirumavalavan N; Han S; Reis IM; Ramasamy R J Urol; 2023 Jul; 210(1):162-170. PubMed ID: 37126399 [TBL] [Abstract][Full Text] [Related]
30. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone. Reyes-Vallejo L; Lazarou S; Morgentaler A J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806 [TBL] [Abstract][Full Text] [Related]
31. Improvements in semen parameters in men treated with clomiphene citrate-A retrospective analysis. Sharma D; Zillioux J; Khourdaji I; Reines K; Wheeler K; Costabile R; Kavoussi P; Smith R Andrologia; 2019 Jun; 51(5):e13257. PubMed ID: 30779195 [TBL] [Abstract][Full Text] [Related]
32. Annual variation in semen characteristics and plasma hormone levels in men undergoing vasectomy. Reinberg A; Smolensky MH; Hallek M; Smith KD; Steinberger E Fertil Steril; 1988 Feb; 49(2):309-15. PubMed ID: 3123279 [TBL] [Abstract][Full Text] [Related]
33. Coadministration of anastrozole sustains therapeutic testosterone levels in hypogonadal men undergoing testosterone pellet insertion. Mechlin CW; Frankel J; McCullough A J Sex Med; 2014 Jan; 11(1):254-61. PubMed ID: 24119010 [TBL] [Abstract][Full Text] [Related]
34. The Utility of Sex Hormone-Binding Globulin in Hypogonadism and Infertile Males. Ring J; Welliver C; Parenteau M; Markwell S; Brannigan RE; Köhler TS J Urol; 2017 May; 197(5):1326-1331. PubMed ID: 28087298 [TBL] [Abstract][Full Text] [Related]
35. EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM. Cunningham G; Belkoff L; Brock G; Efros M; Gittelman M; Carrara D; Neijber A; Ando M; Mitchel J Endocr Pract; 2017 May; 23(5):557-565. PubMed ID: 28225313 [TBL] [Abstract][Full Text] [Related]
36. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men. Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ J Androl; 1998; 19(6):761-8. PubMed ID: 9876028 [TBL] [Abstract][Full Text] [Related]
37. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function. Chiang HS; Hwang TI; Hsui YS; Lin YC; Chen HE; Chen GC; Liao CH Int J Impot Res; 2007; 19(4):411-7. PubMed ID: 17538639 [TBL] [Abstract][Full Text] [Related]
38. The effect of mesterolone on sperm count, on serum follicle stimulating hormone, luteinizing hormone, plasma testosterone and outcome in idiopathic oligospermic men. Varma TR; Patel RH Int J Gynaecol Obstet; 1988 Feb; 26(1):121-8. PubMed ID: 2892728 [TBL] [Abstract][Full Text] [Related]
39. Testicular function in a birth cohort of young men. Hart RJ; Doherty DA; McLachlan RI; Walls ML; Keelan JA; Dickinson JE; Skakkebaek NE; Norman RJ; Handelsman DJ Hum Reprod; 2015 Dec; 30(12):2713-24. PubMed ID: 26409015 [TBL] [Abstract][Full Text] [Related]
40. Decrease in semen quality and Leydig cell function in infertile men: a longitudinal study. Olesen IA; Joensen UN; Petersen JH; Almstrup K; Rajpert-De Meyts E; Carlsen E; McLachlan R; Juul A; Jørgensen N Hum Reprod; 2018 Nov; 33(11):1963-1974. PubMed ID: 30247578 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]